- Implantable Pulse Generators (IPG)
ReConnectNeuro designs and develops active implantable medical devices for therapy specific applications that range from Parkinson's Disease to chronic pain management. The company's licensed Cornell University patents describe more than 15 years of medical research for traumatic brain injuries, a common medical occurrence that currently has no cure. ReConnectNeuro's mission is to improve the quality of life for those who suffer from these injuries and illnesses. Their hope is to complete the development of the active implantable medical devices by 2020 and to commercialize the devices throughout the world.
Med-Ally is the parent company of ReConnectNeuro.
The CEO of ReConnectNeuro is an alumni of the Sibley School of Mechanical and Aerospace Engineering. The company's foundational technologies are licensed from Cornell University. Upper management often visits Cornell job fairs to recruit students.